ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 163 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $426,653 | -22.8% | 134,591 | +21.1% | 0.00% | – |
| Q2 2023 | $552,545 | -86.2% | 111,176 | -86.2% | 0.00% | -100.0% |
| Q1 2023 | $3,997,567 | -0.9% | 808,224 | +26.1% | 0.00% | 0.0% |
| Q4 2022 | $4,034,000 | -51.4% | 641,188 | -16.8% | 0.00% | -66.7% |
| Q3 2022 | $8,306,000 | -30.4% | 770,883 | -26.4% | 0.00% | -25.0% |
| Q2 2022 | $11,942,000 | +30.0% | 1,047,565 | +3.9% | 0.00% | +33.3% |
| Q1 2022 | $9,188,000 | -13.8% | 1,008,536 | +41.1% | 0.00% | 0.0% |
| Q4 2021 | $10,664,000 | +8.7% | 714,662 | +87.2% | 0.00% | 0.0% |
| Q3 2021 | $9,813,000 | +1217.2% | 381,830 | +1236.0% | 0.00% | – |
| Q2 2021 | $745,000 | -13.3% | 28,581 | +17.4% | 0.00% | – |
| Q1 2021 | $859,000 | +16.2% | 24,347 | -16.8% | 0.00% | – |
| Q4 2020 | $739,000 | -36.2% | 29,274 | -4.8% | 0.00% | – |
| Q3 2020 | $1,159,000 | -21.5% | 30,743 | -10.9% | 0.00% | -100.0% |
| Q2 2020 | $1,477,000 | – | 34,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |